| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| TRAVERSA SERGIO | Chief Executive Officer, Director | C/O RELMADA THERAPEUTICS, INC., 2222 PONCE DE LEON BLVD, 3RD FLOOR, CORAL GABLES, | /s/ Sergio Traversa | 30 Jun 2025 | 0001565832 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RLMD | Stock Option (right to buy) | Award | $0 | +800,000 | $0.000000 | 800,000 | 26 Jun 2025 | Common Stock | 800,000 | $0.6700 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The options vest in 16 equal quarterly installments commencing on September 26, 2025. |